Leslie Citrome

21.7k total citations · 2 hit papers
435 papers, 13.3k citations indexed

About

Leslie Citrome is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pharmacology. According to data from OpenAlex, Leslie Citrome has authored 435 papers receiving a total of 13.3k indexed citations (citations by other indexed papers that have themselves been cited), including 325 papers in Psychiatry and Mental health, 107 papers in Clinical Psychology and 76 papers in Pharmacology. Recurrent topics in Leslie Citrome's work include Schizophrenia research and treatment (289 papers), Bipolar Disorder and Treatment (132 papers) and Treatment of Major Depression (70 papers). Leslie Citrome is often cited by papers focused on Schizophrenia research and treatment (289 papers), Bipolar Disorder and Treatment (132 papers) and Treatment of Major Depression (70 papers). Leslie Citrome collaborates with scholars based in United States, Canada and United Kingdom. Leslie Citrome's co-authors include Jan Volavka, Pál Czobor, Joseph P. McEvoy, Jean-Pierre Lindenmayer, Thomas B. Cooper, Jeffrey A. Lieberman, Brian Sheitman, Miranda Chakos, Terence A. Ketter and Joshua T. Kantrowitz and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Leslie Citrome

419 papers receiving 12.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Use of Long-Acting Injectable Antipsychotics in Schizophrenia

2016 275 citations Christoph U. Correll, Leslie Citrome et al. The Journal of Clinical Psychiatry profile →
Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update

2022 136 citations Leslie Citrome et al. profile →

Peers

Countries citing papers authored by Leslie Citrome

Since Specialization

Citations

This map shows the geographic impact of Leslie Citrome's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leslie Citrome with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leslie Citrome more than expected).

Fields of papers citing papers by Leslie Citrome

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leslie Citrome. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leslie Citrome. The network helps show where Leslie Citrome may publish in the future.

Co-authorship network of co-authors of Leslie Citrome

This figure shows the co-authorship network connecting the top 25 collaborators of Leslie Citrome. A scholar is included among the top collaborators of Leslie Citrome based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leslie Citrome. Leslie Citrome is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Choosing among the long-acting injectable antipsychotics: an evidence-based pragmatic guide 2025 ·CNS Spectrums ·Leslie Citrome	0
2	Xanomeline and Trospium Chloride Versus Placebo for the Treatment of Schizophrenia: A Post Hoc Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to Be Helped or Harmed 2025 ·Neuropsychiatric Disease and Treatment ·Leslie Citrome, Nichole M. Neugebauer‎, (unknown), Judith C. Kando	3
3	Comparative efficacy and safety of daridorexant, lemborexant, and suvorexant for insomnia: a systematic review and network meta-analysis 2025 ·Translational Psychiatry ·Taro Kishi, Toshikazu Ikuta, Leslie Citrome, Kenji Sakuma, Masakazu Hatano, (unknown), (unknown), Nakao Iwata	2
4	Aripiprazole Lauroxil: Development and Evidence-Based Review of a Long-Acting Injectable Atypical Antipsychotic for the Treatment of Schizophrenia 2025 ·Neuropsychiatric Disease and Treatment ·Leslie Citrome, Christoph U. Correll, Andrew J. Cutler, Martin Dunbar, (unknown), (unknown), Gregory W. Mattingly, (unknown), Bhaskar Rege, Peter J. Weiden, David McDonnell	2
5	Efficacy of HP-3070, A Once-Daily Asenapine Transdermal System, in the Treatment of Adults with Schizophrenia: A PANSS Five-Factor Analysis 2024 ·Neuropsychiatric Disease and Treatment ·Leslie Citrome, Mariacristina Castelli, Masami Hasebe, Takaaki Terahara, Justin Faden, (unknown)	2
6	TV-46000, A Long-Acting Subcutaneous Antipsychotic Agent, Demonstrated Improved Patient-Centered Outcomes in Patients with Schizophrenia 2024 ·Neuropsychiatric Disease and Treatment ·Leslie Citrome, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Marko A. Mychaskiw, John M. Kane	3
7	Effect of Zuranolone on Concurrent Anxiety and Insomnia Symptoms in Women With Postpartum Depression 2023 ·The Journal of Clinical Psychiatry ·Kristina M. Deligiannidis, Leslie Citrome, (unknown), Sarah Acaster, Moshe Fridman, Vijayveer Bonthapally, Robert Lasser, Stephen Kanes	32
8	Number needed to treat and number needed to harm: What are they good for? 2023 ·European Neuropsychopharmacology ·Leslie Citrome	5
9	Chatbots, ChatGPT, and Scholarly Manuscripts: WAME Recommendations on ChatGPT and Chatbots in Relation to Scholarly Publications 2023 ·Open Access Macedonian Journal of Medical Sciences ·Chris Zielinski, Margaret A. Winker, Rakesh Aggarwal, Lorraine E. Ferris, Markus Heinemann, José Florencio F. Lapeña, Sanjay A Pai, Edsel Ing, Leslie Citrome	17
10	The effects of early initiation of aripiprazole once-monthly on healthcare resource utilization and healthcare costs in individuals with schizophrenia: real-world evidence from US claims data 2023 ·Journal of Medical Economics ·Heidi C. Waters, (unknown), Maëlys Touya, (unknown), Sandipan Bhattacharjee, Leslie Citrome	0
11	Perceived Burdens and Educational Needs of Caregivers of People with Schizophrenia: Results of a National Survey Study 2022 ·SHILAP Revista de lepidopterología ·Leslie Citrome, (unknown), (unknown), (unknown), Marko A. Mychaskiw, Gregory D. Salinas	12
12	Examining the safety, efficacy, and patient acceptability of inhaled loxapine for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults 2019 ·SHILAP Revista de lepidopterología ·(unknown), Leslie Citrome	1
13	Relationships between clinical scales and binge eating days in adults with moderate to severe binge eating disorder in two Phase III studies 2018 ·Neuropsychiatric Disease and Treatment ·Leslie Citrome, Judith C. Kando, Caleb Bliss	6
14	A trial evaluating gradual- or immediate-switch strategies from risperidone, olanzapine, or aripiprazole to iloperidone in patients with schizophrenia 2014 ·Schizophrenia Research ·Peter J. Weiden, Leslie Citrome, Gus Alva, Matthew Brams, Ira D. Glick, (unknown), Gregory W. Mattingly, Farid Kianifard, Xiangyi Meng, Linda Pestreich, Marla Hochfeld, (unknown)	16
15	Depot Antipsychotic Use in New York State Hospitals, 1994 to 2009 2010 ·Psychiatric Services ·Leslie Citrome, Ari Jaffe, Jerome Levine	1
16	Paliperidone palmitate - review of the efficacy, safety and cost of a new second-generation depot antipsychotic medication 2009 ·International Journal of Clinical Practice ·Leslie Citrome	82
17	Adjunctive lithium and anticonvulsants for the treatment of schizophrenia: what is the evidence? 2008 ·Expert Review of Neurotherapeutics ·Leslie Citrome	54
18	Intramuscular Aripiprazole in the Control of Agitation 2007 ·Journal of Psychiatric Practice ·Glenn W. Currier, Leslie Citrome, Dan Zimbroff, Dan A. Oren, George Manos, Robert D. McQuade, (unknown), David Crandall	20
19	The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia 2005 ·Neuroscience Letters ·Daniel J. Müller, Tim Klempan, Vincenzo De Luca, Tricia Sicard, Jan Volavka, Pál Czobor, Brian Sheitman, Jean-Pierre Lindenmayer, Leslie Citrome, Joseph P. McEvoy, Jeffrey A. Lieberman, William G. Honer, James L. Kennedy	77
20	Antipsychotic-Induced Weight Gain and Therapeutic Response: A Differential Association 2002 ·Journal of Clinical Psychopharmacology ·Pál Czobor, Jan Volavka, Brian Sheitman, Jean-Pierre Lindenmayer, Leslie Citrome, Joseph P. McEvoy, Thomas B. Cooper, Miranda Chakos, Jeffrey A. Lieberman	147

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact